Epigraph: A vaccine design tool applied to an HIV therapeutic vaccine and a pan-filovirus vaccine

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Theiler, James ^a,b   Yoon, Hyejin ^a   Yusim, Karina ^a,b   Picker, Louis J ^c   Fruh, Klaus ^c   Korber, Bette ^a,b  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b NEW MEXICO CONSORTIUM   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

FILOVIRIDAE; FILOVIRUS INFECTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PROCEDURES; SEQUENCE ANALYSIS; SOFTWARE;

AIDS VACCINES; EPITOPES; FILOVIRIDAE; FILOVIRIDAE INFECTIONS; HIV INFECTIONS; HIV-1; HUMANS; SEQUENCE ANALYSIS, PROTEIN; SOFTWARE;

EID: 84990196396     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep33987     Document Type: Article

References (51)

1. Fischer, W. et al. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. Plos One 5, e12303 (2010).
2. Liu, M. K. et al. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. J. Clinical Investigation 123, 380-393 (2013).
3. Bar, K. J. et al. Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathogens 8, e1002721 (2012).
4. Liao, H. X. et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496, 469-476 (2013).
5. Korber, B., Letvin, N. L. and Haynes, B. F. T cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces. J. Virology 83, 8300-8314 (2009).
6. Stephenson, K. E. et al. Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeys. J. Virology 86, 11434-11440 (2012).
7. Gaschen, B. et al. Diversity considerations in HIV-1 vaccine selection. Science 296, 2354-2360 (2002).
8. Hulot, S. L. et al. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost. J. Virology 89, 6462-6480 (2015).
9. Fischer, W. et al. Polyvalent vaccines for optimal coverage of potential T cell epitopes in global HIV-1 variants. Nature Medicine 13, 100-106 (2007).
10. Barouch, D. et al. Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nature Medicine 16, 319-323 (2010).
11. Barouch, D. et al. Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys. Cell 155, 531-539 (2013).
12. Ndhlovu, Z. M. et al. Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells. J. Immunology 186, 6914-6924 (2011).
13. Santra, S. et al. Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nature Medicine 16, 324-328 (2010).
14. Santra, S. et al. Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens. Virology 428, 121-127 (2012).
15. Abdul-Jawad, S. et al. Increased valency of conserved-mosaic vaccines enhances the breadth and depth of epitope recognition. Molecular Therapy, doi: 10.1038/mt.2015.210 (2015).
16. Yang, O. O. et al. Short Conserved Sequences of HIV-1 Are Highly Immunogenic and Shift Immunodominance. J. Virology 89, 1195-1204 (2015).
17. Yusim, K. et al. Hepatitis C genotype 1 mosaic vaccines are immunogenic in mice and induce stronger T-cell responses than natural strains. Clinical and Vaccine Immunology 20, 302-305 (2013).
18. Fenimore, P. W. et al. Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage. Plos One 7, e44769 (2012).
19. Kamlangdee, A., Kingstad-Bakke, B., Anderson, T. K., Goldberg, T. L. and Osorio, J. E. Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene. J. Virology 88, 13300-13309 (2014).
20. Epigraph Tool Suite. http://www.hiv.lanl.gov/content/sequence/EPIGRAPH/epigraph.html (2016) (Date of access: 20 June 2016).
21. Hansen, S. G. et al. Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science 340, 1237874 (2013).
22. Hansen, S. G. et al. Immune clearance of highly pathogenic SIV infection. Nature 502, 100-104 (2013).
23. Letourneau, S. et al. Design and pre-clinical evaluation of a universal HIV-1 vaccine. Plos One 2, e984 (2007).
24. Kulkarni, V. et al. Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques. Plos One 9, e86254 (2014).
25. Ondondo, B. et al. Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection. Molecular Therapy 24, 832-842 (2016).
26. Mosaic explanation. http://www.hiv.lanl.gov/content/sequence/MOSAIC/mosaic-explanation.html (2012) (Date of access: 20 June 2016).
27. HIV alignments. http://www.hiv.lanl.gov/content/sequence/NEWALIGN/align.html (2016) (Date of access: 20 June 2016).
28. Mothe, B. et al. Definition of the viral targets of protective HIV-1-specific T cell responses. J. Translational Medicine 9, 208 (2011).
29. Sullivan, N. J. et al. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nature Medicine 17, 1128-1131 (2011).
30. Zhou, Y. and Sullivan, N. J. Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine. Current Opinion in Immunology 35, 131-136 (2015).
31. Carroll, S. A. et al. Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J. Virology 87, 2608-2616 (2013).
32. Yusim, K. et al. Integrated sequence and immunology filovirus database at Los Alamos. Database (Oxford) 2016 (2016).
33. Filovirus and HFV Sequence Alignments. http://hfv.lanl.gov/content/sequence/NEWALIGN/align.html (2015) (Date of access: 20 June 2016).
34. Outbreaks Chronology: Ebola Virus Disease. http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html (2016) (Date of access: 20 June 2016).
35. Marburg Hemorrhagic Fever Distribution Map. http://www.cdc.gov/vhf/marburg/resources/distribution-map.html (2014) (Date of access: 20 June 2016).
36. Negredo, A. et al. Discovery of an ebolavirus-like filovirus in Europe. Plos Pathogens 7, e1002304 (2011).
37. Kuhn, J. H. et al. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch. Virology 159, 1229-1237 (2014).
38. Kuhn, J. H. et al. Evaluation of perceived threat differences posed by filovirus variants. Biosecurity and Bioterrorism 9, 361-371 (2011).
39. Holtsberg, F. W. et al. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses. J. Virology 90, 266-278 (2015).
40. Henao-Restrepo, A. M. et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet (2015).
41. Hagberg, A. A., Schult, D. A. and Swart, P. J. Exploring network structure, dynamics, and function using NetworkX. In Proceedings of the 7th Python in Science Conference (SciPy2008), 11-15 (Pasadena, CA USA, 2008).
42. Gag CTL/CD8+ Epitope Map. http://www.hiv.lanl.gov/content/immunology/maps/ctl/Gag.html (2016) (Date of access: 11 August 2016).
43. de Bruijn, N. G. A combinatorial problem. Proc. Koninklijke Nederlandse Akademie van Wetenschappen. Series A 49, 758-764 (1946).
44. Pevzner, P. A., Tang, H. and Waterman, M. S. An Eulerian path approach to DNA fragment assembly. Proc. National Academy of Science 98, 9748-9753 (2001).
45. Compeau, P. E. C., Pevzner, P. A. and Tesler, G. How to apply de Bruijn graphs to genome assembly. Nature Biotechnology 29, 987-991 (2011).
46. Gross, J. L., Yellen, J. and Zhang, P. Handbook of Graph Theory, 2nd edn (CRC Press, Taylor and Francis Group, Boca Raton, FL, 2014).
47. Smith, T. F. and Waterman, M. S. Identification of common molecular subsequences. J. Molecular Biology 147, 195-197 (1981).
48. Giegerich, R. A systematic approach to dynamic programming in bioinformatics. Bioinformatics 16, 665-677 (2000).
49. Garey, M. and Johnson, D. Computers and Intractability: A Guide to the Theory of NP-Completeness (W. H. Freeman, New York, 1979).
50. Chen, J., Liu, Y., Lu, S., OSullivan, B. and Razgon, I. A fixed-parameter algorithm for the directed feedback vertex set problem. J. ACM 55, 21, 1-21, 19 (2008).
51. Tarjan, R. E. Depth-first search and linear graph algorithms. SIAM J. Computing 1, 146-160 (1972).